CAPR stock price has benefited from sector-wide optimism as biotech ETFs surged 3% this week. Traders are monitoring MACD crossovers for confirmation of sustained bullish momentum. This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market. CAPR stock traded up $0.16 during midday trading on Thursday, hitting $6.20. The company's stock had a trading volume of 485,463 shares, compared to its average volume of 1,926,592. Capricor Therapeutics has a twelve month low of $4.59 and a twelve month high of $23.40. The company's fifty day moving average price is $7.31 and its 200 day moving average price is $9.71. The stock has a market capitalization of $283.46 million, a P/E ratio of -3.78 and a beta of 0.73. CAPR’s stock price patterns show strong support near $4.05, with buyers stepping in aggressively at dips. This could indicate confidence tied to upcoming corporate updates.
